Moritz Gerstung

@moritzgerstung.bsky.social

Scientist developing AI for oncology. Division head at the German Cancer Research Centre DKFZ. Prof at the University of Heidelberg, Germany. Previously at EMBL-EBI and Wellcome Sanger Institute. Alumnus of ETH Zurich.

🚨 new glioblastoma preprint alert! we present the first spatially resolved single cell atlas comparing radionecrotic changes (RN) and recurrent IDH-wildtype glioblastoma (GB) –– shedding light on a long-standing diagnostic challenge. 🧵 1/

Bild

What if you could get a glimpse of the future of your health, today? Our scientists have developed a new generative AI model, trained using large-scale health records, that can estimate how human health may change over time. Watch to find out more. 🖥️🧬

Resharing here a recent X post. In this preprint, we introduce an improved version of NanoSeq, a duplex sequencing protocol with <5 errors per billion bp in single DNA molecules, and use it to study the somatic mutation landscape of oral epithelium in >1000 people. 1/ www.medrxiv.org/content/10.1...

Somatic mutation and selection at epidemiological scale

As we age, many tissues become colonised by microscopic clones carrying somatic driver mutations ([1][1]–[10][2]. Some of these clones represent a first step towards cancer whereas others may contribu...

medrxiv.org